Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma
Bixia Tang, Jiazhi Mo, Xieqiao Yan, Rong Duan, Zhihong Chi, Chuanliang Cui, Lu Si, Yan Kong, Lili Mao, Siming Li, Li Zhou, Bin Lian, Xuan Wang, Xue Bai, Huayan Xu, Caili Li, Jie Dai, Jun Guo, Xinan Sheng
Topics & Concepts
MedicineAxitinibInternal medicineAdverse effectMelanomaClinical endpointGastroenterologyOncologyRegimenProgressive diseaseSurgeryClinical trialCancerChemotherapyCancer researchSunitinibCutaneous Melanoma Detection and ManagementMelanoma and MAPK PathwaysBrain Metastases and Treatment